MIT Engineers Develop 'Mini Livers' for Injection

Breakthrough technology could help patients with failing livers.

Published on Mar. 4, 2026

Got story updates? Submit your updates here. ›

Scientists at the Massachusetts Institute of Technology (MIT) have created "mini livers" that can be injected into the body to help take over the functions of a failing liver. This breakthrough development could provide a new treatment option for patients with liver disease or failure.

Why it matters

Liver disease and failure are major health issues, often requiring invasive transplant surgery. These injectable "mini livers" could offer a less-invasive alternative that allows the body to regain liver function without a full transplant procedure.

The details

The MIT researchers have engineered these "mini livers" using human liver cells and a specialized scaffold material. The mini livers are small enough to be injected into the body, where they can then integrate with the patient's existing liver tissue and take over critical functions like filtering toxins from the blood.

  • The mini liver technology was developed by scientists at MIT in 2026.

The players

Massachusetts Institute of Technology (MIT)

A prestigious private research university located in Cambridge, Massachusetts, known for its groundbreaking work in science and engineering.

Got photos? Submit your photos here. ›

What’s next

The mini liver technology still needs to go through further testing and clinical trials before it could be approved for use in patients with liver disease.

The takeaway

This innovative approach from MIT researchers offers hope for a less invasive treatment option for those suffering from liver failure, potentially reducing the need for full transplant surgery.